Skip to content
Bending the Curve Trial by Trial
?

Nottingham randomised controlled trial of faecal-occult-blood screening for colorectal cancer

N = 152,850

Population
People aged 45 to 74 years living in the Nottingham area, UK.
Design
Randomised trial; 152,850 people aged 45 to 74 in the Nottingham area recruited between February 1981 and January 1991 were allocated to faecal-occult-blood screening or no screening (controls were not told about the study). Haemoccult test kits were sent by family doctors, tests were not rehydrated, and people with a negative first test were invited again every two years; screening ended in February 1995 after three to six offers. People with a positive test were offered colonoscopy.
Primary endpoint
Colorectal cancer mortality
Arms
  • Screening group (experimental, n = 76,466): Haemoccult faecal-occult-blood test every two years, not rehydrated
  • Control group (control, n = 76,384): No screening; not told about the study
People
Hardcastle JD
Primary publication: Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472-7. PubMedDOI

Appears in

Sources

  1. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472-7.

    PubMedDOI